It is notable that ASK1 independently mapped to both the NAFLD and apoptosis pathways (as delineated by KEGG) as this protein is known to be involved in hepatic steatosis and fibrosis [47]. This evidence concerns the gene MAP3K5 and metabolic dysfunction-associated steatotic liver disease.